Candida auris recently emerged as an urgent public health threat, causing outbreaks of
invasive infections in healthcare settings throughout the world. This fungal pathogen persists …

Candida auris is an emerging fungal pathogen with unusual evolutionary history—there are
multiple distinct phylogeographic clades showing a near simultaneous transition from a …

Candida auris is an emerging fungal pathogen responsible for health care–associated
outbreaks that arise from persistent surface and skin colonization. We characterized the …

Biofilm-associated polymicrobial infections tend to be challenging to treat. Candida albicans
and Staphylococcus aureus are leading pathogens due to their ability to form biofilms on …

Candida auris, an emerging multi-drug-resistant fungal pathogen, uniquely colonizes the
human skin long term, leading to subsequent development of life-threatening invasive …

Candida auris has been described as an emerging yeast species during the last decade. As
many as 25% of its strains may naturally exhibit multi-drug resistance to the currently …

Aspergillus fumigatus and Candida auris are historically problematic fungal pathogens
responsible for systemic infections and high mortality rates, especially in …

Background Candida auris infections have been reported worldwide since the pathogen
was isolated in 2009. Aim To analyse the incidence of cutaneous and intestinal colonization …

Candida auris, an emerging multi-drug resistant fungal pathogen, causes invasive infections
in humans. The factors regulating the colonization of C. auris in host niches are not well …

Candida auris has emerged as a problematic fungal pathogen associated with high
morbidity and mortality. Amphotericin B (AmB) is the most effective antifungal used to treat …